J&J-incubated gene therapy startup joins the big leagues
To view this email as a web page, click here

Today's Rundown

Featured Story

Fore fires CEO Malik after SEC insider trading charges during his time as Immunomedics CFO

The SEC charged former Immunomedics Chief Financial Officer Usama Malik with insider trading during his time at the biopharma, now owned by Gilead. As a result, Malik was fired as CEO and director of his current employer, Fore Biotherapeutics, where he lasted less than a year.

read more

Top Stories

Little European biotech Sotio nabs a super $316M funding round for its superagonist work

In one of the biggest funding rounds for a European biotech ever, Czech Republic cancer company Sotio Biotech has grabbed a huge 280 million euro ($316 million) raise.

read more

Gene therapy startup bursts forth from incubation at J&J and F-Prime, graduating with $80M and a Novartis veteran at the helm

AviadoBio has come flying out the traps surrounded by A-list names. Incubated at F-Prime Capital and Johnson & Johnson’s JJDC, AviadoBio exited stealth with $80 million from backers such as New Enterprise Associates and a C-suite led by Novartis veteran Lisa Deschamps. 

read more

Sponsored: Optimize Scale-Up for Vaccine and Therapeutic Manufacturing

Accelerate development by focusing on optimizing an entire biomanufacturing workflow. Thermo Scientific Production Chemicals and Services shares insights on how to achieve successful scale-up.

read more

BeyondSpring lurches down as FDA rejects plinabulin, raising questions about lung cancer prospects

The BeyondSpring roller coaster has plunged downward again. While BeyondSpring wowed investors with its phase 3 lung cancer data in August, the FDA found less to like in another indication, rejecting the drug on the grounds that the single registrational trial was too flimsy to show the drug’s benefit.

read more

Biden’s omicron battle plan includes private insurance reimbursement for at-home COVID tests

Nearly two years after the Trump administration tasked private health insurers with reimbursing the total costs of point-of-care COVID tests and health services, Biden will expand that requirement to include at-home tests, too.

read more

PCMA pulls lawsuit over rebate disclosure rule after reaching deal with Biden admin

The PCMA pulled a federal lawsuit that challenged a Trump administration rule that required PBMs to publicly release drug rebate amounts.

read more

More growth on the way for CSL? Australian giant in talks to buy Vifor for $7.1B: report

Australian biotech giant CSL is negotiating with Vifor Pharma to acquire the Swiss company for A$10 billion ($7.1 billion), says the Australian Financial Review. The acquisition would become the largest ever for CSL.

read more

Fierce Pharma Asia—China’s insulin price cut; Astellas-Dyno gene therapy deal; Fujifilm’s U.K. investment

Novo Nordisk, Sanofi and Eli Lilly offered big discounts for their insulin products in China. Astellas teamed up with Dyno Therapeutics on viral vectors for gene therapy. Fujifilm is lining up $530 million to expand its U.K. facility. And more.

read more

Chutes & Ladders—GlaxoSmithKline snags Pfizer vax leader Dormitzer

GlaxoSmithKline poached Pfizer's RNA and viral vaccines leader Phil Dormitzer, M.D., Ph.D., to shore up its vaccine business as it's lost many research staffers this past year. Parthenon Therapeutics snagged Johnson & Johnson's global head of cell therapy platform and discovery, Tamas Oravecz, Ph.D. And Rafael parted ways with five execs and reinstalled telecom tycoon Howard Jonas as CEO.

read more

Resources

Whitepaper: Patients Want Choice in Accessing and Participating in Clinical Trials

Create more inclusive clinical trials, enroll them faster, and keep participants engaged longer with the latest Study Voices survey results and insights.

Whitepaper: Demand Planning for New Drug/Device Combination

Download now to learn how GLG helped a biotech company plan for the demand of a new drug/device combination by commissioning a forecasting study.

Whitepaper: Tailored, Dedicated Support Expedites COVID-19 Vaccine Trial

Sites receiving augmentation support enroll more than 30,000 patients in just over three months. See how additional site resources can make a difference.

Whitepaper: Healthcare Technical Due Diligence: Assessing a New Cancer Treatment

Download now to learn how GLG helped a biotech company plan for the demand of a new drug/device combination by commissioning a forecasting study.

Guide: Top 10 Considerations When Implementing Machine Translation

If you’re thinking about leveraging the benefits of increased quality, reduced costs, and shortened turnaround times that machine translation (MT) has to offer, check out this quick guide for the top 10 considerations when implementing MT.

Whitepaper: Medable was able to cut costs in multiple clinical trials by over US$25,000,000

Find out how to improve clinical protocol adherence, and thus patient outcomes, by 15%+ with Medable’s latest White Paper.

Webinar: Using Next Best to Elevate your Omnichannel Marketing Strategy

Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making.

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

2021 Report: Clinical Trial Management in a Post-Pandemic World

New market research provides valuable insight into the impact of adaptations made in clinical trials during the pandemic.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Events